Automating study start-up enables faster site activation, better collaboration with study partners, and more informed decision-making. That’s why sponsors and contract research organizations (CROs) are turning to technology specifically designed to manage the intricacies of study start-up, with adoption increasing in 2020.
Hear how Bayer optimizes study start-up with new change-management techniques and other pandemic learnings.